Skip to main content
Emily Browne, DNP, RN, CPNP

Emily Browne, DNP, RN, CPNP

  • Director, Transition Oncology Program
  • Certified Pediatric Nurse Practitioner


BS (Biology) - Birmingham-Southern College
MSN/PNP - Vanderbilt University School of Nursing
DNP – Vanderbilt University School of Nursing 

Clinical Interests

  • Evidence-based practice
  • Childhood obesity prevention
  • Transition needs of early childhood cancer survivors

Selected Publications

Browne E, Zhou Y, Chemaitilly W, Panetta J, Ness K, Kaste, S, Cheng C, Relling M, Pui, C-H, Inaba H. Changes in body mass index, height, and weight in children during and after therapy for acute lymphoblastic leukemia. Cancer  2018 (in press).

Browne E, Moore C, Lu Z, Sykes A, Jeha S, Mandrell B.  Clinical characteristics of intravenous PEG-asparaginase hypersensitivity reactions in patients undergoing treatment for acute lymphoblastic leukemia. J Pediatr Oncol Nurs 35(2), 2018. PMID: 29161979

Woods D, Winchester K, Towerman A, Gettinger K, Carey C, Timmerman K, Langley R, Browne E. From the Children’s Oncology Group: Evidence-based recommendations for PEG-asparaginase nurse monitoring, hypersensitivity reaction management, and patient/family education. J Pediatr Oncol Nurs 34(6), 2017. PMID: 28602129

Eissa HM, Zhou Y, Panetta JC, Browne EK, Jeha S, Cheng C, . . . Inaba H. The effect of body mass index at diagnosis on clinical outcome in children with newly diagnosed acute lymphoblastic leukemia. Blood Cancer J 7(2), 2017.  PMID:  28212374

Last update: October 2018